1. CD38+ CD58− is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients. (April 2016) Authors: Li, Xu-Mian; Zhang, Le-Ping; Wang, Ya-Zhe; Lu, Ai-Dong; Chang, Yan; Zhu, Hong-Hu; Qin, Ya-Zhen; Lai, Yue-Yun; Kong, Yuan; Huang, Xiao-Jun; Liu, Yan-Rong Journal: Leukemia research Issue: Volume 43(2016:Apr.) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients. Issue 2 (January 2016) Authors: Qin, Ya-Zhen; Jiang, Qian; Jiang, Hao; Lai, Yue-Yun; Zhu, Hong-Hu; Liu, Yan-Rong; Jiang, Bin; Huang, Xiao-Jun Editors: Chen., Guoqiang Journal: Medicine Issue: Volume 95:Issue 2(2016) Page Start: e2486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients. Issue 2 (January 2016) Authors: Qin, Ya-Zhen; Jiang, Qian; Jiang, Hao; Lai, Yue-Yun; Zhu, Hong-Hu; Liu, Yan-Rong; Jiang, Bin; Huang, Xiao-Jun Other Names: Chen. Guoqiang section editor. Journal: Medicine Issue: Volume 95:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib. Issue 6 (3rd June 2017) Authors: Qin, Ya-Zhen; Jiang, Qian; Lai, Yue-Yun; Jiang, Hao; Shi, Hong-Xia; Zhao, Xiao-Su; Liu, Yan-Rong; Huang, Xiao-Jun Journal: Leukemia & lymphoma Issue: Volume 58:Issue 6(2017) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation. Issue 1 (December 2016) Authors: Qin, Ya-Zhen; Wang, Yu; Zhu, Hong-Hu; Gale, Robert; Zhang, Mei-Jie; Jiang, Qian; Jiang, Hao; Xu, Lan-Ping; Chen, Huan; Zhang, Xiao-Hui; Liu, Yan-Rong; Lai, Yue-Yun; Jiang, Bin; Liu, Kai-Yan; Huang, Xiao-Jun Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patients with Philadelphia-positive leukemia with Y253H or F359V mutation have a high risk of developing new mutations in the setting of dasatinib resistance. Issue 7 (July 2015) Authors: Jiang, Qian; Qin, Ya-Zhen; Lai, Yue-Yun; Jiang, Hao; Wang, Jing; Huang, Xiao-Jun Journal: Leukemia & lymphoma Issue: Volume 56:Issue 7(2015:Jul.) Page Start: 2075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. Issue 7 (1st July 2013) Authors: Qin, Ya-Zhen; Zhu, Hong-Hu; Liu, Yan-Rong; Wang, Ya-Zhe; Shi, Hong-Xia; Lai, Yue-Yun; Xu, Lan-Ping; Liu, Dai-Hong; Jiang, Qian; Li, Ling-Di; Jiang, Bin; Liu, Kai-Yan; Huang, Xiao-Jun Journal: Leukemia & lymphoma Issue: Volume 54:Issue 7(2013:Jul.) Page Start: 1442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. Issue 7 (July 2013) Authors: Qin, Ya-Zhen; Zhu, Hong-Hu; Liu, Yan-Rong; Wang, Ya-Zhe; Shi, Hong-Xia; Lai, Yue-Yun; Xu, Lan-Ping; Liu, Dai-Hong; Jiang, Qian; Li, Ling-Di; Jiang, Bin; Liu, Kai-Yan; Huang, Xiao-Jun Journal: Leukemia & lymphoma Issue: Volume 54:Issue 7(2013:Jul.) Page Start: 1442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia. Issue 1 (1st January 2021) Authors: Lu, Run-Qing; Wu, Li-Xin; Zhang, Jing; Qin, Ya-Zhen; Liu, Yan-Rong; Lai, Yue-Yun; Jiang, Hao; Chang, Ying-Jun; Ruan, Guo-Rui; Huang, Xiao-Jun Journal: Hematology Issue: Volume 26:Issue 1(2021) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: A multicenter prospective study of 2302 patients in China. Issue 5 (May 2015) Authors: Lai, Yue-Yun; Huang, Xiao-Jun; Li, Juan; Zou, Ping; Xu, Ze-Feng; Sun, Hui; Shao, Zong-Hong; Zhou, Dao-Bin; Chen, Fang-Ping; Liu, Zhuo-Gang; Zhu, Huan-Ling; Wu, De-Pei; Wang, Chun; Zhang, Yin; Li, Yan; Hou, Ming; Du, Xin; Wang, Xin; Li, Wei; Lai, Yong-Rong Journal: Leukemia research Issue: Volume 39:Issue 5(2015:May) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗